{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:47:17Z","timestamp":1790164037981,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010890","name":"Chinese Government Scholarship","doi-asserted-by":"crossref","award":["CSC 2013422002"],"award-info":[{"award-number":["CSC 2013422002"]}],"id":[{"id":"10.13039\/501100010890","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372853"],"award-info":[{"award-number":["81372853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472447"],"award-info":[{"award-number":["81472447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Provincial Climbing Scholars Supporting Program of China"},{"name":"Program for Changjiang Scholars and Innovative Research Team in University","award":["IRT13049"],"award-info":[{"award-number":["IRT13049"]}]},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["502537"],"award-info":[{"award-number":["502537"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bbcan.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T01:34:44Z","timestamp":1428284084000},"page":"254-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chemopreventive effects of aspirin at a glance"],"prefix":"10.1016","volume":"1855","author":[{"given":"Muhammad Waqas","family":"Usman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean J.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pixu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2015.03.007_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(97)07087-6","article-title":"One hundred years of aspirin","volume":"350","author":"Jack","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0015","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1096\/fasebj.5.9.1907252","article-title":"Human platelet\/erythroleukemia cell prostaglandin G\/H synthase: cDNA cloning, expression, and gene chromosomal assignment","volume":"5","author":"Funk","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amepre.2005.08.042","article-title":"Aspirin use among U.S. adults: behavioral risk factor surveillance system","volume":"30","author":"Ajani","year":"2006","journal-title":"Am. J. Prev. Med."},{"issue":"06","key":"10.1016\/j.bbcan.2015.03.007_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4236\/health.2012.46049","article-title":"Prevalence of daily or near daily aspirin use by US adults with diabetes: a cross-sectional study using a multi-year national database","volume":"04","author":"Akers","year":"2012","journal-title":"Health"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djk132","article-title":"A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence","volume":"99","author":"Jacobs","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0045","doi-asserted-by":"crossref","first-page":"e57578","DOI":"10.1371\/journal.pone.0057578","article-title":"Dose\u2013risk and duration\u2013risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0055","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/j.gastro.2013.11.005","article-title":"Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case\u2013control analysis of a population-based cohort","volume":"146","author":"Cardwell","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0060","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0065","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamainternmed.2014.511","article-title":"Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer","volume":"174","author":"Reimers","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0070","doi-asserted-by":"crossref","first-page":"233re232","DOI":"10.1126\/scitranslmed.3008481","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)","volume":"6","author":"Fink","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0075","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/jnci\/djt331","article-title":"Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations","volume":"105","author":"Nan","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0080","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10552-011-9847-z","article-title":"Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO)","volume":"22","author":"McCormack","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.lungcan.2012.03.005","article-title":"Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer","volume":"77","author":"Lim","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopha.2013.11.006","article-title":"Aspirin reduces lung cancer metastasis to regional lymph nodes","volume":"68","author":"Ogawa","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0095","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/annonc\/mdq779","article-title":"Aspirin use and risk for lung cancer: a meta-analysis","volume":"22","author":"Oh","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10620-014-3349-2","article-title":"Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus","volume":"60","author":"Schneider","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0105","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/bjc.2014.127","article-title":"Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis","volume":"110","author":"Zhang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1751-2980.12047","article-title":"Role of aspirin in chemoprevention of esophageal adenocarcinoma: a meta-analysis","volume":"14","author":"Sivarasan","year":"2013","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0115","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ijc.28823","article-title":"Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative","volume":"135","author":"Brasky","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-010-1074-x","article-title":"Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study","volume":"126","author":"Bardia","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0130","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-13-2679","article-title":"Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I\u2013III breast cancer: a nationwide population-based cohort study","volume":"74","author":"Barron","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0135","doi-asserted-by":"crossref","first-page":"606.1","DOI":"10.1096\/fasebj.27.1_supplement.606.1","article-title":"Aspirin prevents growth and differentiation of breast cancer cells: lessons from in vitro and in vivo studies","volume":"27","author":"Maity","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/EDE.0b013e3182456ad3","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer","volume":"23","author":"Lo-Ciganic","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0145","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2014.12.010","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival","author":"Nagle","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1741-7015-12-55","article-title":"Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0160","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11255-014-0703-4","article-title":"Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies","volume":"46","author":"Huang","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.CCR-14-2235","article-title":"Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study","volume":"21","author":"Vidal","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/annonc\/mdt428","article-title":"A cohort study investigating aspirin use and survival in men with prostate cancer","volume":"25","author":"Flahavan","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0175","doi-asserted-by":"crossref","first-page":"e71522","DOI":"10.1371\/journal.pone.0071522","article-title":"Frequency\u2013risk and duration\u2013risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0180","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/bjc.2013.73","article-title":"Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer","volume":"108","author":"Wilson","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0185","article-title":"Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis","author":"Ungprasert","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0190","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/1055-9965.EPI-13-1284","article-title":"Case\u2013control study of aspirin use and risk of pancreatic cancer","volume":"23","author":"Streicher","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0195","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","article-title":"Aspirin dose and duration of use and risk of colorectal cancer in men","volume":"134","author":"Chan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0205","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjmed.2010.12.022","article-title":"Long-term use of aspirin and the risk of gastrointestinal bleeding","volume":"124","author":"Huang","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-128-9-199805010-00003","article-title":"Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study","volume":"128","author":"Sturmer","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0215","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/23810","article-title":"A new target for aspirin","volume":"396","author":"O'Neill","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0225","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","article-title":"Cyclooxygenase-independent actions of cyclooxygenase inhibitors","volume":"15","author":"Tegeder","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0230","first-page":"388","article-title":"The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis","volume":"8","author":"Smith","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1517\/17460441.2014.883377","article-title":"The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies","volume":"9","author":"Vosooghi","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0240","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00018-008-7511-x","article-title":"NSAIDs and apoptosis","volume":"65","author":"Jana","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/gb-2004-5-9-241","article-title":"The cyclooxygenases","volume":"5","author":"Chandrasekharan","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0255","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0260","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Bambace","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.seminoncol.2014.04.008","article-title":"Platelets, cyclooxygenases, and colon cancer","volume":"41","author":"Guillem-Llobat","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1073\/pnas.61.1.46","article-title":"Antimetastatic effects associated with platelet reduction","volume":"61","author":"Gasic","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 2","key":"10.1016\/j.bbcan.2015.03.007_bb0275","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0049-3848(14)50025-4","article-title":"Mechanistic explanation for platelet contribution to cancer metastasis","volume":"133","author":"Stegner","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0285","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(72)92581-0","article-title":"Anti-metastatic effect of aspirin","volume":"2","author":"Gasic","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0290","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0300","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cts.12070","article-title":"Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy","volume":"6","author":"Holmes","year":"2013","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0305","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ajh.21732","article-title":"Normal ranges of angiogenesis regulatory proteins in human platelets","volume":"85","author":"Peterson","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0310","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1158\/1078-0432.CCR-07-4640","article-title":"Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer","volume":"14","author":"Holmes","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0315","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14728222.2014.860447","article-title":"Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness","volume":"18","author":"Bocca","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-14-1","article-title":"Over-expression of COX-2 mRNA in colorectal cancer","volume":"14","author":"Roelofs","year":"2014","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0330","doi-asserted-by":"crossref","first-page":"29797","DOI":"10.1074\/jbc.M313989200","article-title":"Colon carcinoma cell growth is associated with prostaglandin E2\/EP4 receptor-evoked ERK activation","volume":"279","author":"Pozzi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0335","doi-asserted-by":"crossref","first-page":"G673","DOI":"10.1152\/ajpgi.00584.2006","article-title":"PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation","volume":"293","author":"Leone","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0340","first-page":"362","article-title":"Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells","volume":"58","author":"Sheng","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0345","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1172\/JCI22218","article-title":"Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation","volume":"114","author":"Tessner","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0350","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0355","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/1541-7786.MCR-07-2144","article-title":"Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation","volume":"6","author":"Ansari","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0360","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.1116221","article-title":"Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis","volume":"310","author":"Castellone","year":"2005","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm0302-289","article-title":"Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy","volume":"8","author":"Pai","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0370","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mc.20333","article-title":"Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling","volume":"46","author":"Repasky","year":"2007","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0375","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccr.2004.08.011","article-title":"Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta","volume":"6","author":"Wang","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0380","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0385","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ijc.24757","article-title":"Cyclooxygenase-2 inhibition inhibits PI3K\/AKT kinase activity in epithelial ovarian cancer","volume":"126","author":"Uddin","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0390","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/ph5121346","article-title":"Mechanistic and pharmacological issues of aspirin as an anticancer agent","volume":"5","author":"Dovizio","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1607-551X(09)70076-2","article-title":"Effect of aspirin and indomethacin on prostaglandin E2 synthesis in C6 glioma cells","volume":"20","author":"Hwang","year":"2004","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0400","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0405","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0410","first-page":"12","article-title":"NF-kappaB tumorigenesis and drug developement","volume":"21","author":"Liu","year":"2005","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0415","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0420","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/MCB.24.3.1007-1021.2004","article-title":"Suppression of PTEN expression by NF-kappa B prevents apoptosis","volume":"24","author":"Vasudevan","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0425","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1940-6207.CAPR-13-0337","article-title":"Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment","volume":"7","author":"Yue","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0430","doi-asserted-by":"crossref","first-page":"e1003553","DOI":"10.1371\/journal.pgen.1003553","article-title":"NSAIDs modulate clonal evolution in Barrett's esophagus","volume":"9","author":"Kostadinov","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0435","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/em.1033","article-title":"Human DNA repair genes","volume":"37","author":"Ronen","year":"2001","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L","article-title":"Human DNA repair systems: an overview","volume":"33","author":"Yu","year":"1999","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0445","first-page":"383","article-title":"A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells","volume":"9","author":"Goel","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0450","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc07-9917","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"30","author":"Buse","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0455","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement","volume":"150","author":"USPSTF","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0460","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0465","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7015-4-22","article-title":"Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications","volume":"4","author":"Hernandez-Diaz","year":"2006","journal-title":"BMC Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0470","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0475","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2036.2002.01230.x","article-title":"Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin","volume":"16","author":"Lanas","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0480","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0485","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1161\/01.STR.0000174189.81153.85","article-title":"Risk of hemorrhagic stroke with aspirin use: an update","volume":"36","author":"Gorelick","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.bbcan.2015.03.007_bb0490","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-146-5-200703060-00008","article-title":"Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement","volume":"146","author":"USPSTF","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0495","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0500","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0505","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/eurheartj\/ehl056","article-title":"Aspirin and clopidogrel resistance: an emerging clinical entity","volume":"27","author":"Johns","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0510","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncpcardio0728","article-title":"Drug insight: aspirin resistance\u2014fact or fashion?","volume":"4","author":"Patrono","year":"2007","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2015.03.007_bb0515","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/bcp.12432","article-title":"Aspirin influences megakaryocytic gene expression leading to upregulation of multidrug resistance protein-4 in human platelets","volume":"78","author":"Massimi","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0520","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2013.08.005","article-title":"Mechanisms of aspirin resistance","volume":"141","author":"Floyd","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2015.03.007_bb0525","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.2013.6599","article-title":"Aspirin use and risk of colorectal cancer according to BRAF mutation status","volume":"309","author":"Nishihara","year":"2013","journal-title":"JAMA"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X15000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X15000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T10:57:15Z","timestamp":1651661835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X15000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0304419X15000220"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2015.03.007","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemopreventive effects of aspirin at a glance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}